Vimarsana
Biggest News Aggregation in the World

Page 39 - Topline News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Topline. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Topline Today - Breaking & Trending Today

What Manchin wanted, rejected and got in Biden's $2T bill - Vimarsana News

What Manchin wanted, rejected and got in Biden's $2T bill

WASHINGTON (AP) — During a private meeting in July, Sen. Joe Manchin and Majority...

Source: ctpost.com
What Manchin wanted, rejected and got in Biden's $2T bill - Vimarsana News

What Manchin wanted, rejected and got in Biden's $2T bill

WASHINGTON (AP) — During a private meeting in July, Sen. Joe Manchin and Majority...

What Manchin wanted, rejected and got in Biden's $2T bill - Vimarsana News

What Manchin wanted, rejected and got in Biden's $2T bill

WASHINGTON (AP) — During a private meeting in July, Sen. Joe Manchin and Majority...

Alzamend Neuro Shares Up After Alzheimer's Trial Data - Vimarsana News

Alzamend Neuro Shares Up After Alzheimer's Trial Data

By Michael Dabaie Alzamend Neuro Inc. shares rose 10% to $2.79 Friday after the company said it received positive topline data from a Phase 1 clinical trial for AL001 in dementia related to... | December 17, 2021

Pharma Two B Ltd.: Pharma Two B Announces Positive Topline Results from its Pivotal Phase III Study of P2B001 in Early Parkinson's Disease - Vimarsana News

Pharma Two B Ltd.: Pharma Two B Announces Positive Topline Results from its Pivotal Phase III Study of P2B001 in Early Parkinson's Disease

Study successfully met its primary and key secondary endpoints, demonstrating superior efficacy of P2B001 compared to its individual components P2B001 showed comparable efficacy to a marketed